Public policies for the detection of breast cancer in Mexico;Políticas públicas para la detección del cáncer de mama en México

Salud Publica de Mexico

Volumn 51, Issue SUPPL.2, 2009, Pages

  Martínez Montañez, Olga Georgina ^a   Uribe Zúñiga, Patricia ^a   Hernández Ávila, Mauricio ^a  

^a SECRETARÍA DE SALUD   (Mexico)

Author keywords

Breast cancer prevention; Breast neoplasms; Health public policy; Mexico

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; MEXICO; MIDDLE AGED; POLICY; PRACTICE GUIDELINE; PUBLIC HEALTH;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MEXICO; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PUBLIC HEALTH; PUBLIC POLICY;

EID: 77952576712     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/S0036-36342009000800028     Document Type: Article

References (47)

1. Organización Mundial de la Salud. Cáncer. [Consultado el 25 de octubre de 2008]. Disponible en: http://www.who.int/mediacentre/factsheets/fs297/es/index.html.
2. Levi F, Bosetti C, Lucchini F, Negri E, La Vecchia C. Monitoring the decrease in breast cancer mortality in Europe. Eur J Cancer Prev 2005;14(6):497-502.
3. Jatoi I, Chen BE, Anderson WF, Rosenberg PS. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 2007;25(13):1683-1690.
4. Cleries R, Ribes J, Esteban L, Martinez JM, Borra JM. Time trends of breast cancer mortality in Spain during the period 1977-2001 and Bayesian approach for projections during 2002-2016. Ann Oncol 2006;17:1783-1791.
5. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003;39:1718-1729.
6. Robles SC, Galanis E. Breast cancer in Latin America and the Caribbean. Rev Panam Salud Publica/Pan Am J Public Health 2002;11(3):178-184.
7. López-Ríos O, Lazcano-Ponce EC, Tovar-Guzmán V, Hernández-Avila M. La epidemia de cáncer de mama en México. ¿Consecuencia de la transición demográfica? Salud Publica Mex 1997;39:259-265.
8. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 2005; 34:405-412.
9. International Agency for Research on Cancer. GLOBOCAN 2002. [Consultado el 18 de octubre de 2008]. Disponible en: http://www-dep.iarc.fr/.
10. González-Pier E, Gutiérrez-Delgado C, Stevens G, Barraza-Lloréns M, Porras-Condey R, Carvalho N, et al. Definición de prioridades para las intervenciones de salud en el Sistema de Protección Social en Salud de México. Salud Publica Mex 2007;49(Supl. 1):S37-S52.
11. Rodríguez-Cuevas S, Macías CG, Franceschi D, Labastida S. Breast carcinoma presents a decade earlier in Mexican women than in women in the United States or European countries. Cancer 2001;91:863-868.
12. CDC. Home, trends in health and aging home, resident population, nation and state. Age, sex and race. [Consultado el 18 de octubre de 2008]. Disponible en: http://www.cdc.gov/nchs/agingact.htm.
13. Instituto Nacional de Estadística, Geografía e Informática. Proyecciones de la población con base en el Conteo 2005. México: INEGI, 2008.
14. Kahn H, Sempos C. Adjustement of data without use of multivariate models. In: Statistical methods in epidemiology. New York: Oxford University Press, 1989:85-136.
15. Moolgavkar S, Stevens R, Lee J. Effect of age on incidence of breast cancer in females. J Natl Cancer Inst 1979;62:493-501.
16. Rostgaard K, Vaeth M, Holst H, Madsen M, Lynge E. Age-period-cohor modelling of breast cancer incidence in the Nordic countries. Statist Med 2001; 20:47-61.
17. Leung GM, Thach TQ, Lam TH, Hedley AJ, Foo W, Fielding R, et al. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. Brit J Cancer 2002; 87: 982-988.
18. La condición social de la mujer. En: La población de México en el nuevo siglo. México: CONAPO 2001. [Consultado el 20 de diciembre de 2008]. Disponible en: http://www.conapo.gob.mx/publicaciones/La poblacion.htm
19. Zuñiga E, Zubieta B, Araya C. Cuadernos de salud reproductiva. República Méxicana. México: CONAPO 2000. [Consultado el 20 de diciembre de 20008]. Disponible en: http://www.conapo.gob.mx/publicaciones/Cua-salud.htm.
20. Romieu I, Hernandez-Avila M, Lazcano E, Lopez L, Romero-Jaime R. Breast cancer and lactation history in mexican women. Am J Epidemiol 1996;143:543-552.
21. Romieu I, Lazcano-Ponce E, Sanchez-Zamorano LM, Willett W, Hernandez-Avila M. Carbohydrates and the risk of breast cancer among mexican women. Cancer Epidemiol Biomark Prev 2004;13(8):1283-1289.
22. Guendelman S, Abram B. Dietary intake among mexican-american women: generational differences and a comparison with white non-hispanic women. Am J Public Health 1995;85:20-25.
23. Ortiz-Rodríguez SP, Torres-Mejía G, Mainero-Ratchelous F, Ángeles-Llerenas A, López-Caudana AE, Lazcano-Ponce E, et al. Actividad física y riesgo de cáncer de mama en mujeres mexicanas. Salud Publica Mex 2008;50:126-135.
24. McCann J, Stockton D, Day N. Breast cancer in East Anglia: the impact of the breast screen programme on stage at diagnosis. J Med Screen 1998;5:42-48.
25. Lim SE, Back M, Quek E, Lau P, Putti T, Wong J. Clinical observations from a breast cancer registry in asian women. World J Surg 2007; 31: 1387-1392.
26. Kosters JP, Gotzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. [Systematic Review] Cochrane Breast Cancer Group Cochrane Database of Systematic Reviews. 3, 2008.
27. Barton MB, Fletcher SW, Harris R. Clinical breast examination for detecting breast cancer. JAMA 2000;283(13):1687-1689.
28. Miller AB, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000;92:1490-1499.
29. International Agency for Research on Cancer Working Group on the Evaluation of Cancer Preventive Strategies. Efficacy of screening by breast self examination. In: Vaionio H, Bianchini F, eds. Breast cancer screening. Lyon: IARC Press, 2002:107-113.
30. HSTAT: Guide to Clinical Preventive Services, 3rd ed. Recommendations and Systematic Evidence Reviews, Guide to Community Preventive Services, U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews,15. Screening for Breast Cancer. [Consultado el 21 de noviembre de 208]. Disponible en: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat3.section.27512
31. Tabar L, Yen MF, Vitak B, Chen HHT, Smith RA, Duffy SW. Mamography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction and screening. Lancet 2003; 361:1405-1410.
32. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography in women 40-49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007;146:516-526.
33. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, et al. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomized controlled trial. Lancet 2006;368:2053-2060.
34. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Systematic Review] Cochrane Breast Cancer Group Cochrane Database of Systematic Reviews. 3, 2008
35. Gray JAM, Patnick J, Blanks RG. Maximising benefit and minimising harm of screening. BMJ 2008;336;480-483.
36. WHO. National cancer control programmes: policies and managerial guidelines. 2nd ed. Geneva: WHO, 2002:62-63.
37. IARC. Handbooks of cancer prevention. Vol 7. Breast cancer screening. Vainio H, Bianchini F, eds. New York: Oxford University Press, 2002.
38. Shapiro S, Coleman EA, Broeders M, Codd M, Koning H, Franchebound J, et al. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol 1998;27:735:742.
39. European guidelines for quality assurance in breast cancer screeening and diagnosis. 4th ed. European communities, 2006.
40. Blamey RW, Cataliotti L. EUSOMA accrediation of breast units. Eur J Cancer 2006;42:1331-1337.
41. Lazcano-Ponce EC, Najera-Aguilar P. The cervical cancer screening program in Mexico: problems with access and coverage. Can Caus Control 1997;8 :698-704.
42. Lazcano-Ponce E, Palacio-Mejia LS, Allen-Leigh B, Yunes-Diaz E, Alonso P, Schiavon R, et al. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology. Can Epidemiol Biomar Prev 2008;17(10):2808-2817.
43. Programa Sectorial de Salud 2007-2012. Secretaría de Salud. México 2008. [Consultado el 18 de octubre de 2008]. Disponible en: http://portal.salud.gob.mx.
44. Zapka JG, Taplin SH, Solberg LI, Manos MM. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. Can Epidemiol Biomar Prev 2003;12(1):4-13
45. YabroffKR, Washington KS, Leader A, Neilson E, Mandelblatt J. Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. Med Care Res Rev 2003;60(3):294-331.
46. Zapka JG, Puleo E, Taplin S, Solberg LI, Mouchawar J, Somkin C, et al. Breast and cervical cancer screening: clinicians' views on health plan guidelines and implementation efforts. J Natl Cancer Inst Monogr 2005;(35):46-54.
47. Wall KM, Nuñez-Rocha GM, Salinas-Martinez AM, Sanchez-Peña SR. Determinants of the use of breast cancer screening among women workers in urban Mexico. Prev Chronic Dis 2008;5(2):1-8.